Why the study?
Does aliskiren provide persistent antihypertensive and organoprotective effects compared to losartan in Ren-2 transgenic rats?
Population
Young (32 days old) and adult (100 days old) heterozygous Ren-2 transgenic rats (TGR)
Comparison
Aliskiren 10 mg/kg/day via osmotic minipumps for… vs Losartan 5 mg/kg/day in drinking water for 28…
Design
Preclinical
Follow-up
Up to 70 days of treatment plus 12 days of withdrawal
Authors
Loading...
Aliskiren's persistent effects in Ren-2 rats should not inform clinical decisions; leaves open translation to human hypertension therapy.
Does aliskiren provide persistent antihypertensive and organoprotective effects compared to losartan in Ren-2 transgenic rats?
Aliskiren provides persistent antihypertensive and organoprotective effects, including reduced proteinuria and normalized glomerular size, even after treatment withdrawal in a transgenic rat model of hypertension.
Rakušan et al. (2010) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: